Enclot Injection

About Enclot 500 mg/5 ml Injection

Enclot is an injection of Tranexamic Acid, an anti-fibrinolytic medicine made by Opsonin Pharma Limited. It comes as a 500 mg/5 ml strength in a 5 ml ampoule, given by a healthcare professional to help reduce bleeding in certain conditions.

There are 35 brands of Tranexamic Acid listed in Bangladesh. 19 of them have a lower unit price than Enclot. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.

What is Enclot 500 mg/5 ml Injection?

Enclot Injection is a preparation of Tranexamic Acid, an anti-fibrinolytic drug. It works by blocking the breakdown of blood clots, which helps reduce bleeding in certain medical and surgical situations. The injection is supplied as a 500 mg/5 ml strength in a 5 ml ampoule. Because it is a prescription injection, a doctor or nurse gives it and decides whether it is suitable for the patient, the dose, and how long treatment continues. The decision depends on the patient's condition and medical history.

Uses of Enclot

Enclot Injection is used in medical and surgical settings where Tranexamic Acid helps reduce or prevent bleeding. These include certain bleeding problems linked to leukemia, cirrhosis, hemophilia and low platelets, bleeding linked to clot-dissolving therapy or transfusion, and bleeding during or after operations such as lung and heart surgery. Only the treating doctor can decide whether it is appropriate for a particular patient.

How to use Enclot

Enclot Injection is given by a doctor or trained healthcare professional, usually into a vein, and sometimes into a muscle. Patients do not give it to themselves. The doctor decides the dose and the length of the course based on the patient's condition. Tell the doctor about all other medicines being taken, because some medicines can interact with Tranexamic Acid. Ask the doctor or pharmacist about anything that is unclear.

Side effects of Enclot

Tranexamic Acid is generally well tolerated, but some people may feel fatigue, have eye irritation, a blocked nose, itching or skin redness and rashes. Nausea, diarrhea and stomach burning have been reported after oral use. Rarely, a drop in blood pressure when standing may occur. Anyone with signs of allergy should stop treatment and get medical help. Ask the doctor or pharmacist about any reaction that worries you.

Safety and precautions

Enclot Injection should only be used when a doctor judges it suitable. It is not for people with known allergy to the product, thromboembolic disease, arterial or venous thrombosis, certain internal bleeding, or serious kidney failure. It is not given during known or suspected pregnancy and passes into breast milk in small amounts. People with kidney problems, or those taking estrogen-containing medicines such as oral contraceptives, should tell the doctor first. Ask the doctor before use if any of these apply.

Frequently asked questions

What is the price of Enclot Injection?

The listed price is ৳ 50.19. For the current price and availability, check with the pharmacy or the place where it is dispensed, as prices can change.

What does the generic name Tranexamic Acid mean?

Tranexamic Acid is the generic name of the active substance in Enclot Injection. It is a synthetic amino acid medicine that acts as an anti-fibrinolytic, meaning it helps slow the breakdown of blood clots.

What is Enclot Injection used for and what kind of medicine is it?

It is an anti-fibrinolytic medicine used in certain medical and surgical situations to help reduce or prevent bleeding. The doctor decides whether it is appropriate, based on the patient's condition and history.

What do the dosage form and strength mean?

Enclot is an injection, supplied as a 500 mg/5 ml strength in a 5 ml ampoule, in packs of 5 ampoules. The strength tells how much medicine is in each ampoule. The doctor decides the dose and course; patients do not choose these.

Indications

In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.

In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.

In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.

In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.

In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.

In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.

Pharmacology

This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.

The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.

Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.

Dosage & Administration

Adults-
  • The usual dose: 500-1000 mg 3 times daily.
  • For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
  • For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
  • For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
  • For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.

Interaction

Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.

Contraindications

Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.

Side Effects

  • Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
  • After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
  • There are rare cases of postural hypotension.
  • In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.

Pregnancy & Lactation

Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.

Precautions & Warnings

  • Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
  • The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
  • In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
  • Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
  • The administration of product requires particular care in cardiopathic and hepatopathic subjects.

Storage Conditions

Store in a dry place at 15-30°C, away from light and keep out of children's reach.

Alternative brands of Tranexamic Acid

Other brands with the same generic name, cheapest first.

Anaxyl Capsule

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

Anaxyl Tablet

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

See all 35 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.